Fluxion Therapeutics, a Physiomics™ Company. 
We use the term Physiomics to refer to network-level descriptions of electrophysiological properties and biophysical mechanisms of cells, cell membranes, ion channels, and membrane receptors; with an emphasis on the unique dynamic, continuous, and timescale characteristics of electrophysiology and biophysics, such as changes in excitability, signaling, cellular transport, membrane composition, and others. Physiomics anticipates integrating detailed physical and physiological characterization with more integrated functional perspectives and insights drawn from other ‘omics (genomics, epigenomics, transcriptomics, proteomics, metabolomics, lipidomics, etc.) networks and systems-level in order to better understand these mechanisms and processes. 
Fluxion Therapeutics applies such Physiomics NAMs models to predict Safety&Tox risks.
Additionally, we are building a pipeline of neuropsychiatric and anti-epileptic candidates.

Fluxion Therapeutics

Org chart

Teams

Offices